Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
67%
Ph phase_4
1
33%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Phase 4Post-market surveillance
1(33.3%)
N/ANon-phased studies
2(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(3)

Detailed Status

Completed3

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (33.3%)
N/A2 (66.7%)

Trials by Status

completed3100%

Recent Activity

0 active trials
Showing 3 of 3
completedphase_4

Effects of Capsimax on Appetite, Energy Intake and Blood Pressure

NCT04874701
completednot_applicable

To Evaluate the Efficacy of Capsimax on Metabolic Rate

NCT04025346
completednot_applicable

Capsimax Effect on Metabolic Rate, Satiety and Food Intake

NCT03489226

Clinical Trials (3)

Showing 3 of 3 trials
NCT04874701Phase 4

Effects of Capsimax on Appetite, Energy Intake and Blood Pressure

Completed
NCT04025346Not Applicable

To Evaluate the Efficacy of Capsimax on Metabolic Rate

Completed
NCT03489226Not Applicable

Capsimax Effect on Metabolic Rate, Satiety and Food Intake

Completed

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3